Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alimera Sciences Inc.

    NASDAQ: ALIM · Real-Time Price · USD
    5.54
    -0.01 (-0.18%)
    At close: Sep 13, 2024, 8:00 PM

    Alimera Sciences Statistics

    Share Statistics

    Alimera Sciences has 54.38M shares outstanding. The number of shares has increased by 3.81% in one year.

    Shares Outstanding

    n/a
    		 54.38M

    Shares Change (YoY)

    n/a
    		 3.81%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 85.26%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 3,404,657

    FTD / Avg. Volume

    n/a
    		 392.77%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -5.49 and the forward PE ratio is null. Alimera Sciences's PEG ratio is 0.08.

    PE Ratio

    n/a
    		 -5.49

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.37

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.39

    P/FCF Ratio

    n/a
    		 -1.23

    PEG Ratio

    n/a
    		 0.08
    Financial Ratio History

    Enterprise Valuation

    Alimera Sciences has an Enterprise Value (EV) of 165.74M.

    EV / Sales

    n/a
    		 2.05

    EV / EBITDA

    n/a
    		 22.78

    EV / EBIT

    n/a
    		 -11.62

    EV / FCF

    n/a
    		 -1.85

    Financial Position

    The company has a current ratio of 2.39, with a Debt / Equity ratio of 1.4.

    Current Ratio

    n/a
    		 2.39

    Quick Ratio

    n/a
    		 2.31

    Debt / Equity

    n/a
    		 1.4

    Debt / EBITDA

    n/a
    		 9.26

    Debt / FCF

    n/a
    		 -0.75

    Interest Coverage

    n/a
    		 -0.14

    Financial Efficiency

    Return on Equity is -43.6% and Return on Invested Capital is -1.33%.

    Return on Equity

    n/a
    		 -43.6%

    Return on Assets

    n/a
    		 -13.11%

    Return on Invested Capital

    n/a
    		 -1.33%

    Revenue Per Employee

    n/a
    		 $524,376.62

    Profits Per Employee

    n/a
    		 $-130,727.27

    Employee Count

    n/a
    		 154

    Asset Turnover

    n/a
    		 0.53

    Inventory Turnover

    n/a
    		 10.42

    Taxes

    Income Tax

    n/a
    		 85K

    Effective Tax Rate

    n/a
    		 -0.42%

    Stock Price Statistics

    The stock price has increased by 52.62% in the last 52 weeks. The beta is 1.25, so Alimera Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.25

    52-Week Price Change

    n/a
    		 52.62%

    50-Day Moving Average

    n/a
    		 5.56

    200-Day Moving Average

    n/a
    		 4.21

    Relative Strength Index (RSI)

    n/a
    		 52.49

    Average Volume (20 Days)

    n/a
    		 866,825

    Income Statement

    In the last 12 months, Alimera Sciences had revenue of 80.75M and earned -20.13M in profits. Earnings per share was -0.79.

    Revenue

    n/a
    		 80.75M

    Gross Profit

    n/a
    		 61.17M

    Operating Income

    n/a
    		 -1.47M

    Net Income

    n/a
    		 -20.13M

    EBITDA

    n/a
    		 7.28M

    EBIT

    n/a
    		 -9.86M

    Earnings Per Share (EPS)

    n/a
    		 -0.79
    Full Income Statement

    Balance Sheet

    The company has 12.09M in cash and 67.4M in debt, giving a net cash position of -55.31M.

    Cash & Cash Equivalents

    n/a
    		 12.09M

    Total Debt

    n/a
    		 67.4M

    Net Cash

    n/a
    		 -55.31M

    Retained Earnings

    n/a
    		 -418.49M

    Total Assets

    n/a
    		 150.38M

    Working Capital

    n/a
    		 35.57M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -14.26M and capital expenditures -75.53M, giving a free cash flow of -89.79M.

    Operating Cash Flow

    n/a
    		 -14.26M

    Capital Expenditures

    n/a
    		 -75.53M

    Free Cash Flow

    n/a
    		 -89.79M

    FCF Per Share

    n/a
    		 -3.51
    Full Cash Flow Statement

    Margins

    Gross margin is 75.75%, with operating and profit margins of -1.82% and -24.93%.

    Gross Margin

    n/a
    		 75.75%

    Operating Margin

    n/a
    		 -1.82%

    Pretax Margin

    n/a
    		 -24.82%

    Profit Margin

    n/a
    		 -24.93%

    EBITDA Margin

    n/a
    		 9.01%

    EBIT Margin

    n/a
    		 -1.82%

    FCF Margin

    n/a
    		 -111.19%

    Dividends & Yields

    ALIM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -18.23%

    FCF Yield

    n/a
    		 -81.31%
    Dividend Details

    Analyst Forecast

    The average price target for ALIM is $6, which is 8.3% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 8.3%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 15, 2019. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Nov 15, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -1.43

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist